![Mark W. Womack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark W.
Womack is currently Chief Executive Officer at Selexis SA since 2022.
Formerly, Mr. Womack was Chief Executive Officer at KBI Biopharma, Inc. from 2022 to 2023, Chief Executive Officer at OneSource Specialty Pharma Ltd., Chief Executive Officer at BioCina Pty Ltd. from 2023 to 2025, and Chief Business Officer at AGC Biologics, Inc.
Postes actifs de Mark W. Womack
| Sociétés | Poste | Début |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Directeur Général | 02/05/2022 |
Anciens postes connus de Mark W. Womack
| Sociétés | Poste | Fin |
|---|---|---|
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Directeur Général | 17/04/2023 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Directeur Général | - |
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Commercial Services |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
